Brief: Positive Preliminary Results Demonstrate Autonomix’S Proprietary RF Ablation Technology’S Ability To Reduce Opioid Use In Ongoing Human Clinical Trial
28/10/2024 12:08
Oct 28 (Reuters) - Autonomix Medical Inc AMIX.O :
* POSITIVE PRELIMINARY RESULTS DEMONSTRATE AUTONOMIX’S
PROPRIETARY
RF ABLATION TECHNOLOGY’S ABILITY TO REDUCE OPIOID USE IN ONGOING
HUMAN CLINICAL TRIAL
* AUTONOMIX MEDICAL INC - TWO PATIENTS SUCCUMBED TO DISEASE
POST-PROCEDURE, NOT RELATED TO TRIAL
* AUTONOMIX MEDICAL INC - TRIAL EXPECTED TO COMPLETE
ENROLLMENT BY
YEAR-END 2024
Source text: ID:nGNXGRYJM
Further company coverage: AMIX.O
((Reuters.Briefs@thomsonreuters.com;))